Casdin Capital, LLC Q2 2018 Filing
Filed August 14, 2018
Portfolio Value
$686.5B
Holdings
32
Report Date
Q2 2018
Filing Type
13F-HR
All Holdings (32 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —FOUNDATION MEDICINE INC | 685,000 | $93.6B | 13.64% | |
| 2 | —LOXO ONCOLOGY INC | 380,000 | $65.9B | 9.60% | Put |
| 3 | 2L9BLUEPRINT MEDICINES CORP | 645,000 | $40.9B | 5.96% | Call |
| 4 | SG7SAGE THERAPEUTICS INC | 250,000 | $39.1B | 5.70% | |
| 5 | —MYOKARDIA INC | 780,000 | $38.7B | 5.64% | |
| 6 | —SPARK THERAPEUTICS INC | 463,000 | $38.3B | 5.58% | |
| 7 | —BLUEBIRD BIO INC | 200,000 | $31.4B | 4.57% | |
| 8 | AGIOAGIOS PHARMACEUTICALS INC | 364,776 | $30.7B | 4.48% | |
| 9 | FATEFATE THERAPEUTICS INC | 2,600,000 | $29.5B | 4.29% | |
| 10 | CDXSCODEXIS INC | 2,025,000 | $29.2B | 4.25% | |
| 11 | ALNYALNYLAM PHARMACEUTICALS INC | 270,000 | $26.6B | 3.87% | |
| 12 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 530,000 | $24.0B | 3.49% | Put |
| 13 | VYGRVOYAGER THERAPEUTICS INC | 1,135,000 | $22.2B | 3.23% | |
| 14 | —GENMARK DIAGNOSTICS INC | 3,400,000 | $21.7B | 3.16% | |
| 15 | ILMNILLUMINA INC | 71,500 | $20.0B | 2.91% | |
| 16 | GBYSANGAMO THERAPEUTICS INC | 1,400,000 | $19.9B | 2.90% | |
| 17 | —AUDENTES THERAPEUTICS INC | 450,000 | $17.2B | 2.50% | |
| 18 | CRSPCRISPR THERAPEUTICS AG | 220,000 | $12.9B | 1.88% | |
| 19 | EVHEVOLENT HEALTH INC | 550,000 | $11.6B | 1.69% | |
| 20 | ONCBEIGENE LTD | 70,000 | $10.8B | 1.57% | |
| 21 | EP3ORASURE TECHNOLOGIES INC | 640,000 | $10.5B | 1.54% | |
| 22 | CLVSEURCLOVIS ONCOLOGY INC | 220,000 | $10.0B | 1.46% | |
| 23 | BLFSBIOLIFE SOLUTIONS INC | 1,000,000 | $8.3B | 1.21% | |
| 24 | EDITEDITAS MEDICINE INC | 178,333 | $6.4B | 0.93% | |
| 25 | —MAGENTA THERAPEUTICS INC | 400,000 | $5.4B | 0.79% | |
| 26 | NEOGNEOGEN CORP | 65,000 | $5.2B | 0.76% | |
| 27 | CTMXCYTOMX THERAPEUTICS INC | 207,500 | $4.7B | 0.69% | |
| 28 | ZLABZAI LAB LTD | 135,000 | $3.1B | 0.46% | |
| 29 | JNCEEURJOUNCE THERAPEUTICS INC | 375,000 | $2.9B | 0.42% | |
| 30 | CDNACAREDX INC | 200,000 | $2.4B | 0.36% | |
| 31 | FIXXEURHOMOLOGY MEDICINES INC | 115,000 | $2.3B | 0.34% | |
| 32 | —NEON THERAPEUTICS INC | 75,000 | $945.0M | 0.14% |